$5.45 Billion is the total value of Redmile Group, LLC's 81 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 36.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | $504,811,000 | +16.5% | 12,629,737 | 0.0% | 9.27% | +15.8% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $325,830,000 | -13.4% | 23,075,807 | -7.5% | 5.98% | -13.9% |
| IMMU | Sell | IMMUNOMEDICS INC | $275,066,000 | +122.4% | 3,234,934 | -7.3% | 5.05% | +121.2% |
| ARGX | Sell | ARGENX SEsponsored adr | $259,493,000 | +11.3% | 988,468 | -4.5% | 4.76% | +10.7% |
| IGMS | Buy | IGM BIOSCIENCES INC | $252,833,000 | +10.2% | 3,425,455 | +9.0% | 4.64% | +9.6% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $244,953,000 | -17.6% | 4,774,918 | -4.1% | 4.50% | -18.1% |
| ADCT | Buy | ADC THERAPEUTICS SA | $209,589,000 | -19.0% | 6,353,094 | +15.0% | 3.85% | -19.4% |
| ALLK | Sell | ALLAKOS INC | $197,562,000 | +5.0% | 2,425,560 | -7.4% | 3.63% | +4.4% |
| GILD | New | GILEAD SCIENCES INC | $181,353,000 | – | 2,869,962 | +100.0% | 3.33% | – |
| OSH | New | OAK STR HEALTH INC | $141,745,000 | – | 2,652,411 | +100.0% | 2.60% | – |
| ANNX | New | ANNEXON INC | $104,055,000 | – | 3,442,122 | +100.0% | 1.91% | – |
| EPZM | Sell | EPIZYME INC | $99,158,000 | -27.2% | 8,311,633 | -2.1% | 1.82% | -27.7% |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $94,856,000 | -13.3% | 3,344,694 | +11.1% | 1.74% | -13.8% |
| BIIB | Buy | BIOGEN INC | $92,890,000 | +113.9% | 327,447 | +101.8% | 1.70% | +112.6% |
| NRIX | New | NURIX THERAPEUTICS INC | $90,542,000 | – | 2,593,570 | +100.0% | 1.66% | – |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $89,928,000 | -9.8% | 6,938,870 | +1.4% | 1.65% | -10.3% |
| KYMR | New | KYMERA THERAPEUTICS INC | $88,292,000 | – | 2,732,660 | +100.0% | 1.62% | – |
| SNY | Buy | SANOFIsponsored adr | $87,449,000 | +39.8% | 1,743,048 | +42.2% | 1.60% | +39.0% |
| BNTX | Sell | BIONTECH SEsponsored ads | $85,544,000 | -58.2% | 1,235,645 | -59.7% | 1.57% | -58.5% |
| STOK | Buy | STOKE THERAPEUTICS INC | $85,383,000 | +43.2% | 2,549,506 | +1.9% | 1.57% | +42.4% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $81,917,000 | -12.8% | 3,327,262 | -0.9% | 1.50% | -13.3% |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $79,515,000 | -0.3% | 2,432,408 | +46.4% | 1.46% | -0.9% |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $76,823,000 | -30.6% | 3,391,757 | -0.6% | 1.41% | -31.0% |
| REPL | Buy | REPLIMUNE GROUP INC | $76,680,000 | -0.6% | 3,330,999 | +7.3% | 1.41% | -1.1% |
| RPTX | Buy | REPARE THERAPEUTICS INC | $74,001,000 | -0.0% | 2,404,974 | +0.8% | 1.36% | -0.5% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $71,936,000 | +636.1% | 2,336,357 | +495.8% | 1.32% | +633.9% |
| CI | Sell | CIGNA CORP NEW | $67,204,000 | -26.3% | 396,693 | -18.4% | 1.23% | -26.7% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $66,933,000 | -7.2% | 4,713,600 | -3.9% | 1.23% | -7.7% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $64,659,000 | +10.7% | 1,501,945 | +6.5% | 1.19% | +10.1% |
| ALVR | New | ALLOVIR INC | $64,168,000 | – | 2,333,390 | +100.0% | 1.18% | – |
| NVRO | Sell | NEVRO CORP | $64,024,000 | +7.7% | 459,609 | -7.7% | 1.18% | +7.0% |
| RGNX | Sell | REGENXBIO INC | $61,319,000 | -25.6% | 2,228,166 | -0.4% | 1.13% | -26.0% |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $56,760,000 | +109.3% | 2,793,288 | +58.2% | 1.04% | +108.0% |
| APRE | APREA THERAPEUTICS INC | $54,585,000 | -38.0% | 2,268,718 | 0.0% | 1.00% | -38.3% | |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $54,336,000 | +72.5% | 1,422,049 | +58.5% | 1.00% | +71.5% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $51,317,000 | -2.0% | 2,900,889 | +0.9% | 0.94% | -2.6% |
| ZYME | Buy | ZYMEWORKS INC | $51,313,000 | +81.6% | 1,101,600 | +40.6% | 0.94% | +80.5% |
| NLTX | Buy | NEOLEUKIN THERAPEUTICS INC | $50,072,000 | -25.4% | 4,172,686 | +3.3% | 0.92% | -25.8% |
| RCEL | New | AVITA THERAPEUTICS INC | $44,774,000 | – | 1,779,586 | +100.0% | 0.82% | – |
| QURE | Sell | UNIQURE NV | $41,575,000 | -26.0% | 1,128,827 | -9.5% | 0.76% | -26.4% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $37,827,000 | -9.6% | 741,129 | -37.8% | 0.69% | -10.2% |
| IMGN | Sell | IMMUNOGEN INC | $37,720,000 | -31.7% | 10,477,879 | -12.7% | 0.69% | -32.2% |
| BCEL | Buy | ATRECA INC | $35,598,000 | +68.6% | 2,548,168 | +156.9% | 0.65% | +67.7% |
| DXCM | Sell | DEXCOM INC | $34,385,000 | -12.8% | 83,412 | -14.3% | 0.63% | -13.3% |
| AMED | Sell | AMEDISYS INC | $33,143,000 | -26.2% | 140,180 | -38.0% | 0.61% | -26.7% |
| PPD | Sell | PPD INC | $31,556,000 | -39.1% | 853,092 | -55.9% | 0.58% | -39.5% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $29,500,000 | +13.5% | 1,989,200 | -0.5% | 0.54% | +12.9% |
| ICUI | Sell | ICU MED INC | $28,886,000 | -22.2% | 158,054 | -21.5% | 0.53% | -22.6% |
| CTLT | Sell | CATALENT INC | $28,218,000 | -6.8% | 329,419 | -20.3% | 0.52% | -7.3% |
| PRAH | Sell | PRA HEALTH SCIENCES INC | $28,194,000 | +3.7% | 277,936 | -0.5% | 0.52% | +3.2% |
| SLQT | Buy | SELECTQUOTE INC | $27,445,000 | +118.1% | 1,355,304 | +172.8% | 0.50% | +117.2% |
| TCDA | Buy | TRICIDA INC | $25,897,000 | -55.5% | 2,858,415 | +34.9% | 0.48% | -55.8% |
| LMNX | Sell | LUMINEX CORP DEL | $23,995,000 | -19.6% | 914,107 | -0.4% | 0.44% | -20.0% |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $23,557,000 | -16.8% | 466,205 | -21.5% | 0.43% | -17.4% |
| IMTX | New | IMMATICS N.V | $22,599,000 | – | 2,130,000 | +100.0% | 0.42% | – |
| ARDX | ARDELYX INC | $18,449,000 | -24.1% | 3,514,100 | 0.0% | 0.34% | -24.5% | |
| HOOK | Sell | HOOKIPA PHARMA INC | $17,452,000 | -19.3% | 1,842,902 | -1.0% | 0.32% | -19.8% |
| CTSO | New | CYTOSORBENTS CORP | $16,757,000 | – | 2,101,131 | +100.0% | 0.31% | – |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $15,375,000 | – | 407,400 | +100.0% | 0.28% | – |
| CABA | Sell | CABALETTA BIO INC | $15,031,000 | -5.4% | 1,386,584 | -2.8% | 0.28% | -5.8% |
| PROF | Buy | PROFOUND MED CORP | $14,553,000 | +114.8% | 825,000 | +106.2% | 0.27% | +113.6% |
| XERS | XERIS PHARMACEUTICALS INC | $14,217,000 | +122.9% | 2,397,441 | 0.0% | 0.26% | +121.2% | |
| PAND | New | PANDION THERAPEUTICS INC | $12,831,000 | – | 1,119,600 | +100.0% | 0.24% | – |
| ITMR | ITAMAR MED LTDsponsored ads | $12,713,000 | +9.4% | 625,000 | 0.0% | 0.23% | +8.4% | |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $12,447,000 | +113.0% | 1,719,247 | +2.7% | 0.23% | +112.0% |
| FSDC | New | FS DEV CORP | $11,200,000 | – | 1,000,000 | +100.0% | 0.21% | – |
| STXS | STEREOTAXIS INC | $11,110,000 | -19.7% | 3,103,327 | 0.0% | 0.20% | -20.3% | |
| GDRX | New | GOODRX HLDGS INC | $11,120,000 | – | 200,000 | +100.0% | 0.20% | – |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $11,010,000 | -75.5% | 2,548,620 | -49.7% | 0.20% | -75.6% |
| NVTA | Sell | INVITAE CORP | $8,453,000 | -35.3% | 195,003 | -54.8% | 0.16% | -35.7% |
| GRTS | Sell | GRITSTONE ONCOLOGY INC | $8,108,000 | -60.2% | 3,059,794 | -0.2% | 0.15% | -60.4% |
| AYLA | AYALA PHARMACEUTICALS INC | $7,853,000 | +17.4% | 666,666 | 0.0% | 0.14% | +17.1% | |
| IMVT | Sell | IMMUNOVANT INC | $4,256,000 | -70.9% | 120,940 | -79.8% | 0.08% | -71.1% |
| OM | New | OUTSET MED INC | $3,500,000 | – | 70,000 | +100.0% | 0.06% | – |
| SYRS | SYROS PHARMACEUTICALS INC | $1,877,000 | -17.1% | 212,291 | 0.0% | 0.03% | -19.0% | |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $1,787,000 | – | 744,582 | +100.0% | 0.03% | – |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $1,389,000 | -67.9% | 163,619 | -60.6% | 0.03% | -67.5% |
| OVID | OVID THERAPEUTICS INC | $700,000 | -22.1% | 121,950 | 0.0% | 0.01% | -23.5% | |
| VAPO | VAPOTHERM INC | $725,000 | -29.3% | 25,000 | 0.0% | 0.01% | -31.6% | |
| ODT | Sell | ODONATE THERAPEUTICS INC | $338,000 | -98.7% | 25,162 | -96.0% | 0.01% | -98.8% |
| CSLT | CASTLIGHT HEALTH INCcl b | $12,000 | +50.0% | 10,229 | 0.0% | 0.00% | – | |
| ELGXQ | Exit | ENDOLOGIX INC | $0 | – | -78,755 | -100.0% | -0.00% | – |
| BNR | Exit | BURNING ROCK BIOTECH LTDsponsored ads | $0 | – | -133,931 | -100.0% | -0.07% | – |
| BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -2,467,000 | -100.0% | -0.16% | – |
| RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -200,000 | -100.0% | -0.18% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -297,619 | -100.0% | -0.45% | – |
| TWST | Exit | TWIST BIOSCIENCE CORP | $0 | – | -589,300 | -100.0% | -0.49% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -103,900 | -100.0% | -0.57% | – |
| GMAB | Exit | GENMAB A/Ssponsored ads | $0 | – | -1,057,393 | -100.0% | -0.66% | – |
| NVS | Exit | NOVARTIS AGsponsored adr | $0 | – | -439,800 | -100.0% | -0.71% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -524,300 | -100.0% | -0.75% | – |
| CYRX | Exit | CRYOPORT INC | $0 | – | -1,817,663 | -100.0% | -1.02% | – |
| HRC | Exit | HILL ROM HLDGS INC | $0 | – | -585,000 | -100.0% | -1.19% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -4,705,308 | -100.0% | -2.89% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -2,712,388 | -100.0% | -2.99% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.